Long‐Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti‐MAdCAM‐1 Antibody Ontamalimab: Results From the Open‐Label Extension Study TURANDOT II: 772. (October 2019)